{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:41:04Z","timestamp":1793893264835,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["NIAU01AG009740"],"award-info":[{"award-number":["NIAU01AG009740"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.sapharm.2023.12.008","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T12:07:58Z","timestamp":1703678878000},"page":"363-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Longitudinal medication adherence group-based trajectories of aging adults in the US: A retrospective analysis using monthly proportion of days covered calculations"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3333-1482","authenticated-orcid":false,"given":"Vasco M.","family":"Pontinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave L.","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman V.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D'Arcy","family":"Mays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen B.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Holdford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.12.008_bib1","unstructured":"World Health Organization. Adherence to Long-Term Therapies: Evidence for action. World Health Organization. Accessed 20\/January\/2020, https:\/\/apps.who.int\/medicinedocs\/pdf\/s4883e\/s4883e.pdf."},{"issue":"6","key":"10.1016\/j.sapharm.2023.12.008_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1331\/JAPhA.2013.13082","article-title":"Adherence and persistence associated with an appointment-based medication synchronization program","volume":"53","author":"Holdford","year":"2003","journal-title":"J Am Pharm Assoc"},{"issue":"10","key":"10.1016\/j.sapharm.2023.12.008_bib3","first-page":"27","article-title":"The price you pay for the drug not taken","volume":"16","author":"McCarthy","year":"1998","journal-title":"Bus Health"},{"issue":"5","key":"10.1016\/j.sapharm.2023.12.008_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.sapharm.2023.12.008_bib6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/0003-4819-157-11-201212040-00538","article-title":"Interventions to improve adherence to self-administered medications for chronic diseases in the United States","volume":"157","author":"Viswanathan","year":"2012","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.sapharm.2023.12.008_bib7","doi-asserted-by":"crossref","DOI":"10.2196\/19179","article-title":"Measurement properties of existing patient-reported outcome measures on medication adherence: systematic review","volume":"22","author":"Kwan","year":"2020","journal-title":"J Med Internet Res"},{"issue":"23","key":"10.1016\/j.sapharm.2023.12.008_bib8","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.sapharm.2023.12.008_bib9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther"},{"issue":"5","key":"10.1016\/j.sapharm.2023.12.008_bib10","first-page":"449","article-title":"The association between cost sharing, prior authorization, and specialty drug utilization: a systematic review","volume":"29","author":"Ismail","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.sapharm.2023.12.008_bib11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2147\/CLEP.S333534","article-title":"Measuring medication adherence in a population-based asthma administrative pharmacy database: a systematic review and meta-analysis","volume":"13","author":"Asamoah-Boaheng","year":"2021","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.sapharm.2023.12.008_bib12","series-title":"Health Affairs Health Policy Brief. August 10, 2017","year":"2017"},{"key":"10.1016\/j.sapharm.2023.12.008_bib13","author":"Alliance"},{"key":"10.1016\/j.sapharm.2023.12.008_bib14","unstructured":"Pharmacy Quality Alliance. PQA Measure Use in CMS\u2019 Part D Quality Programs. 18.01.20, Accessed December 10, 2019, https:\/\/www.pqaalliance.org\/medicare-part-d."},{"key":"10.1016\/j.sapharm.2023.12.008_bib15","unstructured":"Centers for Medicare & Medicaid Services. Medicare program; changes to the Medicare advantage and the Medicare prescription drug benefit programs for contract year 2013 and other changes. In: U.S. Centers for Medicare & Medicaid Services, editor.: Federal Register.."},{"issue":"6","key":"10.1016\/j.sapharm.2023.12.008_bib16","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacl.2020.09.005","article-title":"A retrospective cohort study evaluating the relationship between statin medication adherence and economic outcomes in commercial health plans","volume":"14","author":"Chinthammit","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.sapharm.2023.12.008_bib17","first-page":"64","article-title":"Evaluating the relationship between quality measure adherence definitions and economic outcomes in commercial health plans: a retrospective diabetes cohort study","volume":"27","author":"Chinthammit","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2023.12.008_bib18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.sapharm.2023.12.008_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.amjms.2016.01.010","article-title":"Medication adherence: truth and consequences","volume":"351","author":"Brown","year":"2016","journal-title":"Am J Med Sci"},{"issue":"9","key":"10.1016\/j.sapharm.2023.12.008_bib20","first-page":"1138","article-title":"Medication adherence trajectories: a systematic literature review","volume":"26","author":"Alhazami","year":"2020","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2023.12.008_bib21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12325-018-0700-6","article-title":"Medication adherence patterns among patients with multiple serious mental and physical illnesses","volume":"35","author":"MacEwan","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.sapharm.2023.12.008_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ahj.2017.09.019","article-title":"The relative benefits of claims and electronic health record data for predicting medication adherence trajectory","volume":"197","author":"Franklin","year":"2018","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.sapharm.2023.12.008_bib23","first-page":"e537","article-title":"Predicting adherence trajectory using initial patterns of medication filling","volume":"21","author":"Franklin","year":"2015","journal-title":"Am J Manag Care"},{"issue":"10","key":"10.1016\/j.sapharm.2023.12.008_bib24","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/pds.3787","article-title":"Association between trajectories of statin adherence and subsequent cardiovascular events","volume":"24","author":"Franklin","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.sapharm.2023.12.008_bib25","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MLR.0b013e3182984c1f","article-title":"Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence","volume":"51","author":"Franklin","year":"2013","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.sapharm.2023.12.008_bib26","first-page":"202","article-title":"Group-based trajectory models to identify sociodemographic and clinical predictors of adherence patterns to statin Therapy among older adults","volume":"12","author":"Vadhariya","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"10.1016\/j.sapharm.2023.12.008_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12877-019-1058-6","article-title":"Patterns of antihypertensive and statin adherence prior to dementia: findings from the adult changes in thought study","volume":"19","author":"Marcum","year":"2019","journal-title":"BMC Geriatr. Feb 14"},{"key":"10.1016\/j.sapharm.2023.12.008_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.863876","article-title":"Assessing concurrent adherence to combined essential medication and clinical outcomes in patients with acute coronary syndrome. A population-based, real-world study using group-based trajectory models","volume":"9","author":"Rodriguez-Bernal","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.sapharm.2023.12.008_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1097\/MLR.0000000000001625","article-title":"Comparing continuous and binary group-based trajectory modeling using statin medication adherence data","volume":"59","author":"Hickson","year":"2021","journal-title":"Med Care"},{"key":"10.1016\/j.sapharm.2023.12.008_bib30","unstructured":"Centers for Medicare and Medicaid Services. Medicare 2020 Part C & D Star Ratings Technical Notes. 18.01.20, Accessed January 5, 2020, https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovGenIn\/Downloads\/Star-Ratings-Technical-Notes-Oct-10-2019.pdf."},{"issue":"2","key":"10.1016\/j.sapharm.2023.12.008_bib31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jval.2018.08.006","article-title":"Methods for measuring multiple medication adherence: a systematic review-report of the ISPOR medication adherence and persistence special interest group","volume":"22","author":"Pednekar","year":"2019","journal-title":"Value Health"},{"issue":"7","key":"10.1016\/j.sapharm.2023.12.008_bib32","first-page":"457","article-title":"Measuring concurrent adherence to multiple related medications","volume":"15","author":"Choudhry","year":"2009","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.sapharm.2023.12.008_bib33","unstructured":"Chu L, Kawatkar A, Gu A. A SAS\u00ae macro program to calculate medication adherence rate for single and multiple medication use. Lex Jansen SAS Conference Proceedings website. Accessed 01\/04\/2022, https:\/\/www.lexjansen.com\/wuss\/2011\/hoc\/Papers_Chu_L_74886.pdf."},{"key":"10.1016\/j.sapharm.2023.12.008_bib34","unstructured":"SAS 9.4. SAS Institute Inc.;."},{"issue":"7","key":"10.1016\/j.sapharm.2023.12.008_bib35","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling","volume":"27","author":"Nagin","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.sapharm.2023.12.008_bib36","series-title":"Group-based Modeling of Development","author":"Nagin","year":"2005"},{"issue":"2-3","key":"10.1016\/j.sapharm.2023.12.008_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-based trajectory modeling: an overview","volume":"65","author":"Nagin","year":"2014","journal-title":"Ann Nutr Metab"},{"issue":"1","key":"10.1016\/j.sapharm.2023.12.008_bib38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-statistics-022513-115701","article-title":"Breaking bad: two decades of life-course data analysis in criminology, developmental psychology, and beyond","volume":"1","author":"Erosheva","year":"2014","journal-title":"Annual Rev Statistics Appl"},{"issue":"4","key":"10.1016\/j.sapharm.2023.12.008_bib39","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1177\/0049124113503141","article-title":"A note on a stata plugin for estimating group-based trajectory models","volume":"42","author":"Jones","year":"2013","journal-title":"Socio Methods Res"},{"key":"10.1016\/j.sapharm.2023.12.008_bib40","series-title":"Stata Statistical Software: Release","volume":"vol. 17","year":"2021"},{"issue":"6","key":"10.1016\/j.sapharm.2023.12.008_bib41","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/cpt.865","article-title":"Group-based trajectory models: assessing adherence to antihypertensive medication in older adults in a community pharmacy setting","volume":"103","author":"Dillon","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.sapharm.2023.12.008_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161381","article-title":"Medication adherence patterns after hospitalization for coronary heart disease. A population-based study using electronic records and group-based trajectory models","volume":"11","author":"Librero","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.sapharm.2023.12.008_bib43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","article-title":"The impact of medication regimen factors on adherence to chronic treatment: a review of literature","volume":"31","author":"Ingersoll","year":"2008","journal-title":"J Behav Med"},{"issue":"7653","key":"10.1016\/j.sapharm.2023.12.008_bib44","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.sapharm.2023.12.008_bib45","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jash.2011.01.001","article-title":"Adherence and persistence with taking medication to control high blood pressure","volume":"5","author":"Hill","year":"2011","journal-title":"J Am Soc Hypertens"},{"issue":"4","key":"10.1016\/j.sapharm.2023.12.008_bib46","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares?","volume":"86","author":"Brown","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"23","key":"10.1016\/j.sapharm.2023.12.008_bib47","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.sapharm.2023.12.008_bib48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCOUTCOMES.116.002728","article-title":"Socioeconomic inequalities in statin adherence under universal coverage: does sex matter?","volume":"9","author":"Aarnio","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.sapharm.2023.12.008_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/ijpp.12539","article-title":"The association between pharmacy refill-adherence metrics and healthcare utilisation: a prospective cohort study of older hypertensive adults","author":"Dillon","year":"2019","journal-title":"Int J Pharm Pract"},{"issue":"9","key":"10.1016\/j.sapharm.2023.12.008_bib50","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11606-016-3747-6","article-title":"Trajectories of diabetes medication adherence and hospitalization risk: a retrospective cohort study in a large state Medicaid program","volume":"31","author":"Lo-Ciganic","year":"2016","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.sapharm.2023.12.008_bib51","article-title":"Rates, determinants and success of implementing deprescribing in people with type 2 diabetes: a scoping review","volume":"38","author":"Oktora","year":"2021","journal-title":"Diabet Med. Feb"},{"issue":"12","key":"10.1016\/j.sapharm.2023.12.008_bib52","first-page":"1529","article-title":"Assessing the association between medication adherence, as defined in quality measures, and disease-state control, health care utilization, and costs in a retrospective database analysis of Medicare supplemental beneficiaries using statin medications","volume":"26","author":"Axon","year":"2020","journal-title":"J Manag Care Spec Pharm. Dec"},{"issue":"17","key":"10.1016\/j.sapharm.2023.12.008_bib53","article-title":"Associations of renin-angiotensin system antagonist medication adherence and economic outcomes among commercially insured US adults: a retrospective cohort study","volume":"9","author":"Campbell","year":"2020","journal-title":"J Am Heart Assoc. Sep"},{"issue":"4","key":"10.1016\/j.sapharm.2023.12.008_bib54","first-page":"354","article-title":"Assessing quality of care in pharmacy: remembering donabedian","volume":"24","author":"Rupp","year":"2018","journal-title":"J Manag Care Spec Pharm. Apr"},{"key":"10.1016\/j.sapharm.2023.12.008_bib55","author":"Health"},{"key":"10.1016\/j.sapharm.2023.12.008_bib56","author":"Centers for Medicare & Medicaid Services"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123005004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123005004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:32:02Z","timestamp":1761557522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741123005004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1551741123005004"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.12.008","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal medication adherence group-based trajectories of aging adults in the US: A retrospective analysis using monthly proportion of days covered calculations","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}